Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (73 total)
-
Autor: Leshem, Eyal, and Benjamin Alan Lopman.
Tema: Infection Control
Tipo de elemento: Publicación
Fecha de actualización: 2021-04-23
Descripción: Vaccines act by two broad main mechanisms. They can block infection occurring entirely or they can halt the progression to symptoms after infection occurs. -
Autor: Shaw, Robert H., Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S. Nguyen Van-Tam, and Matthew D. Snape.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-05-12
Descripción: There is significant international interest in heterologous prime-boost COVID-19 vaccination to mitigate against supply shocks or shortages that might otherwise reduce the speed of vaccine roll-out. Additionally, in light of changing recommendations… -
Autor: NETEC
Tema: Treatment & Care
Tipo de elemento: Webinar
Fecha de actualización: 2021-05-21
Descripción: Webinar slides attached.Objectives: Discuss the epidemiology, pathology, symptoms, and diagnosis of Long COVID Describe options for treatment support for Long COVID Explain how the members of the team can provide psychological support for Long COVID… -
Autor: the Overcoming COVID-19 Investigators
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2021-06-16
Descripción: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. -
Autor: Kadri, Sameer S., Junfeng Sun, Alexander Lawandi, Jeffrey R. Strich, Lindsay M. Busch, Michael Keller, Ahmed Babiker, Christina Yek, Seidu Malik, Janell Krack, John P. Dekker, Alicen B. Spaulding, Emily Ricotta, John H. Powers Iii, Chanu Rhee,…
Tema: Emergency Management
Tipo de elemento: Publicación
Fecha de actualización: 2021-07-06
Descripción: Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: The Medical Letter on Drugs and Therapeutics
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2021-07-15
Descripción: COVID-19 Vaccine Comparison Chart (online only) effectiveness by vaccine and by variant. -
Autor: WHO
Tema: General
Tipo de elemento: Hipervínculo
Fecha de actualización: 2021-08-07
Descripción: This WHO fact sheet covers Marburg virus disease: Key facts Transmission Symptoms of Marburg virus disease Diagnosis Treatment and vaccines Marburg virus in animals Prevention and control Controlling infection in healthcare settings Marburg viral… -
Autor: Fintzi J, Bonnett T, Sweeney DA, Huprikar NA, Ganesan A, Frank MG, McLellan SLF, Dodd LE, Tebas P, Mehta AK.
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2021-08-19
Descripción: The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) found that remdesivir therapy hastened recovery in patients hospitalized with COVID-19, but the pathway for this improvement was not explored. We investigated how the dynamics of clinical progression…Conservation strategies: This resource contains recommendations facilitating conservation of equipment and supplies during contingency (expected shortages) and crisis (known shortages) capacities and should not be applied as guidance when conventional capacities are available.
-
Autor: Barda, Noam, Noa Dagan, Yatir Ben-Shlomo, Eldad Kepten, Jacob Waxman, Reut Ohana, Miguel A. Hernán, Marc Lipsitch, Isaac Kohane, Doron Netzer, Ben Y. Reis, and Ran D. Balicer.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-08-25
Descripción: Preapproval trials showed that messenger RNA (mRNA)–based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile, yet these trials were subject to size and patient-mix limitations. An evaluation of the… -
Autor: the COVID-19 Genomics UK (COG-UK) consortium
Tema: Personnel Management
Tipo de elemento: Publicación
Fecha de actualización: 2021-08-27
Descripción: The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. It has since rapidly become the predominant lineage, owing to high transmissibility. It is suspected that the delta variant is associated with more severe disease…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.